Elena Lopareva

Elena Lopareva

Auto-generated profile, based on publicly available information

Elena Lopareva

Centers for Disease Control and Prevention, 1600 Clifton Road N.E., Atlanta, GA 30329, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
BBBettina Bankamp
Bettina Bankamp
RARaydel Anderson
Raydel Anderson
LHLijuan Hao
Lijuan Hao
ELElena Lopareva
Elena Lopareva
MCMin-hsin Chen
Min-hsin Chen
PRPaul Rota
Paul Rota
More than 100 laboratories in the World Health Organization Global Measles and Rubella Laboratory Network (GMRLN) perform nucleic acid-based methods for case confirmation of measles or rubella infections and/or strain surveillance (genotyping). The quality of laboratory data is critical to ensure that diagnostic results and country reports to regional verification committees are based on accurate data. A molecular External Quality Assurance (mEQA) program was initiated by the US-CDC in 2014 to evaluate the performance of laboratories in the network. The inclusion of testing for measles and rubella viruses, with a focus on detection and genotyping, plus the diversity of assays and platforms employed required a flexible and comprehensive proficiency testing program. A stepwise introduction of new evaluation criteria gradually increased the stringency of the proficiency testing program, while giving laboratories time to implement the required changes. The mEQA program plays an important role in many processes in the GMRLN, including informing plans for the training of laboratory staff, access to reagents, and the submission of sequence data to global databases. The EQA program for Local Public Health Institutes in Japan is described as an example for national mEQA programs. As more laboratories initiate molecular testing, the mEQA will need to continue to expand and to adapt to the changing landscape for molecular testing.